arrow_backBack to Catalogue
Metabolic / Weight Management
Tirzepatide
Dual GIP/GLP-1 receptor agonist for comprehensive metabolic balance.
Clinical Profile
- check_circleUnprecedented metabolic optimization
- check_circleComprehensive weight and satiety control
- check_circleImproved cardiovascular health markers
- check_circleHighly effective glycemic regulation
biotech
Mechanism of Action
A first-in-class dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It provides a synergistic effect on glucose control and lipolysis.
medication_liquid
Therapeutic Application
Administered via once-weekly subcutaneous injection starting with a low-dose titration.
Ready to include Tirzepatide in your protocols?
Log in to the prescriber portal to access research monographs, inventory availability, and peer-reviewed clinical studies.